BRISTOL-MYERS: Ex-executive is indicted
April 24th, 2008
Bristol-Myers Squibb has already pleaded guilty and paid a $1 million fine for misleading the government about a patent deal involving the blood-thinning drug Plavix. Now antitrust prosecutors are charging the company’s former senior vice president, Andrew Bodnar, with one count of making a false statement cashadvance.
The indictment says Bodnar lied to the Federal Trade Commission to keep a rival firm from launching of a generic version of Plavix.
Filed under: technology by Specialist